332
Participants
Start Date
September 30, 2019
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
ASTX727
ASTX727 film-coated, immediate-release FDC tablets
Wiener Gesundheitsverbund - Klinik Hietzing 06 FE Study, Vienna
Wiener Gesundheitsverbund - Klinik Hietzing 06 Study, Vienna
Specialized Hospital for Active Treatment of Hematological Disease EAD, Sofia
Complex Oncology Center - Plovdiv - Base II, Plovdiv
Debreceni Egyetem Klinikai Kozpont, Belgyogyszati Klinika, B epulet, Hematologia, Debrecen
Rosewell Park Cancer Institute, Buffalo
Roswell Park Cancer Institute - 06 FE Study, Buffalo
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Institutul Oncologic Bucuresti - Prof. Dr. Alexandru Trestioreanu, Bucharest
Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck
Clínica Universidad de Navarra - Madrid, Madrid
Hospital Universitario 12 de Octubre, Madrid
Charleston Hematology Oncology Associates, Charleston
Hospital Clínico Universitario Virgen de la Arrixaca, Murcia
Boca Raton Clinical Research, Plantation
Vanderbilt - Ingram Cancer Center, Nashville
Städtisches Klinikum Braunschweig, Braunschweig
Gabrail Cancer Center Research - 06 FE Study, Canton
Gabrail Cancer Center Research, Canton
Hospital Universitario La Fe, Valencia
Cancer and Hematology Centers for Western Michigan, Grand Rapids
Mayo - Rochester, Rochester
The University of Chicago Medical Center, Chicago
Hôpital Emile Muller, Mulhouse
Baylor Scott White University Medical Center, Dallas
University of Texas Southwestern Medical Center, Dallas
The University of Texas MD Anderson Cancer Center, Houston
May Cancer Center, San Antonio
Summit Clinical Research s.r.o, Bratislava
Compassionate Care Research Group, Fountain Valley
Oregon Health and Science University, Portland
Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle
Kadlec Clinic Hematology and Oncology, Kennewick
Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca
Hackensack Medical Center - 06 FE Study, Hackensack
Hackensack Medical Center, Hackensack
Erebuni Medical Center, Yerevan
Hematology Center After Prof. R. Yeolyan (Adult Blood Disorders), Yerevan
Hematology Center After Prof. R. Yeolyan (Clinic of Adults Oncology), Yerevan
National Center of Oncology Named After V.A. Fanarjyan, Yerevan
Centrum Badań Klinicznych Piotr Napora Lekarze Sp. p., Wroclaw
Hospital Universitari Arnau de Vilanova, Lleida
University of Alberta Hospital, Edmonton
QEII Health Sciences Centre, Nova Scotia
The Ottawa Hosptial, Ottawa
Sunnybrook Health Sciences Centre, Toronto
Princess Margaret Cancer Center, Toronto
Taiho Oncology, Inc.
INDUSTRY